139 related articles for article (PubMed ID: 34608924)
1. Development of computational models using omics data for the identification of effective cancer metabolic biomarkers.
Lee SM; Kim HU
Mol Omics; 2021 Dec; 17(6):881-893. PubMed ID: 34608924
[TBL] [Abstract][Full Text] [Related]
2. Patient-specific multi-omics models and the application in personalized combination therapy.
John A; Qin B; Kalari KR; Wang L; Yu J
Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
[TBL] [Abstract][Full Text] [Related]
3. Computational resources for identification of cancer biomarkers from omics data.
Kaur H; Kumar R; Lathwal A; Raghava GPS
Brief Funct Genomics; 2021 Jul; 20(4):213-222. PubMed ID: 33788922
[TBL] [Abstract][Full Text] [Related]
4. Two-step multi-omics modelling of drug sensitivity in cancer cell lines to identify driving mechanisms.
Kusch N; Schuppert A
PLoS One; 2020; 15(11):e0238961. PubMed ID: 33226984
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
Liu C; Wang X; Genchev GZ; Lu H
Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
[TBL] [Abstract][Full Text] [Related]
6. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
[TBL] [Abstract][Full Text] [Related]
7. Translating cancer 'omics' to improved outcomes.
Vucic EA; Thu KL; Robison K; Rybaczyk LA; Chari R; Alvarez CE; Lam WL
Genome Res; 2012 Feb; 22(2):188-95. PubMed ID: 22301133
[TBL] [Abstract][Full Text] [Related]
8. Omics and Computational Modeling Approaches for the Effective Treatment of Drug-Resistant Cancer Cells.
Jung HD; Sung YJ; Kim HU
Front Genet; 2021; 12():742902. PubMed ID: 34691155
[TBL] [Abstract][Full Text] [Related]
9. Integrative Analysis of Cancer Omics Data for Prognosis Modeling.
Wang S; Wu M; Ma S
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31405076
[TBL] [Abstract][Full Text] [Related]
10. Imaging and the completion of the omics paradigm in breast cancer.
Leithner D; Horvat JV; Ochoa-Albiztegui RE; Thakur S; Wengert G; Morris EA; Helbich TH; Pinker K
Radiologe; 2018 Nov; 58(Suppl 1):7-13. PubMed ID: 29947931
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
Liu N; Wu Y; Cheng W; Wu Y; Wang L; Zhuang L
BMC Cancer; 2021 Apr; 21(1):460. PubMed ID: 33902514
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and comparison of multi-omics data integration methods for cancer subtyping.
Duan R; Gao L; Gao Y; Hu Y; Xu H; Huang M; Song K; Wang H; Dong Y; Jiang C; Zhang C; Jia S
PLoS Comput Biol; 2021 Aug; 17(8):e1009224. PubMed ID: 34383739
[TBL] [Abstract][Full Text] [Related]
13. Integrative omics analyses broaden treatment targets in human cancer.
Sengupta S; Sun SQ; Huang KL; Oh C; Bailey MH; Varghese R; Wyczalkowski MA; Ning J; Tripathi P; McMichael JF; Johnson KJ; Kandoth C; Welch J; Ma C; Wendl MC; Payne SH; Fenyö D; Townsend RR; Dipersio JF; Chen F; Ding L
Genome Med; 2018 Jul; 10(1):60. PubMed ID: 30053901
[TBL] [Abstract][Full Text] [Related]
14. Identifying Molecular Biomarkers for Diseases With Machine Learning Based on Integrative Omics.
Shi K; Lin W; Zhao XM
IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(6):2514-2525. PubMed ID: 32305934
[TBL] [Abstract][Full Text] [Related]
15. New cancer biomarkers deriving from NCI early detection research.
Verma M; Srivastava S
Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
[TBL] [Abstract][Full Text] [Related]
16. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
17. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
18. Ancient genes can be served as pan-cancer diagnostic and prognostic biomarkers.
Ji X; Cui Q
J Cell Mol Med; 2020 Jun; 24(12):6908-6915. PubMed ID: 32368859
[TBL] [Abstract][Full Text] [Related]
19. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
